Jim Simons Kronos Bio, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 979,054 shares of KRON stock, worth $930,101. This represents 0.0% of its overall portfolio holdings.

Number of Shares

979,054

Previous 764,126 28.13%

Holding current value

$930,101

Previous $947,000 3.38%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.92 - $1.5 $197,733 - $322,392	214,928 Added 28.13%	979,054 $979,000
Q2 2024 Aug 09, 2024	SELL	$0.73 - $1.38 $195,204 - $369,017	-267,404 Reduced 25.92%	764,126 $947,000
Q1 2024 May 13, 2024	BUY	$1.02 - $1.3 $120,976 - $154,185	118,604 Added 12.99%	1,031,530 $1.34 Million
Q4 2023 Feb 13, 2024	SELL	$0.75 - $1.49 $66,580 - $132,273	-88,774 Reduced 8.86%	912,926 $1.14 Million
Q3 2023 Nov 14, 2023	SELL	$1.23 - $2.25 $240,588 - $440,100	-195,600 Reduced 16.34%	1,001,700 $1.3 Million
Q2 2023 Aug 11, 2023	BUY	$1.24 - $1.92 $337,776 - $523,008	272,400 Added 29.45%	1,197,300 $2.06 Million
Q1 2023 May 12, 2023	BUY	$1.34 - $2.62 $102,644 - $200,692	76,600 Added 9.03%	924,900 $1.35 Million
Q4 2022 Feb 13, 2023	BUY	$1.44 - $3.44 $219,309 - $523,905	152,298 Added 21.88%	848,300 $1.37 Million
Q3 2022 Nov 14, 2022	SELL	$3.35 - $5.55 $358,108 - $593,283	-106,898 Reduced 13.31%	696,002 $2.33 Million
Q2 2022 Aug 12, 2022	BUY	$3.12 - $7.52 $1.91 Million - $4.6 Million	612,145 Added 320.91%	802,900 $2.92 Million
Q1 2022 May 13, 2022	BUY	$6.26 - $14.42 $1.1 Million - $2.53 Million	175,255 Added 1130.68%	190,755 $1.38 Million
Q4 2021 Feb 11, 2022	BUY	$11.35 - $21.18 $175,925 - $328,290	15,500 New	15,500 $211,000

Others Institutions Holding KRON

# of Institutions

Shares Held

19.8M

Call Options Held

9.3K

Put Options Held

100

View Full List

About Kronos Bio, Inc.

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

More about KRON

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account